EMDB-48575:
G002-293-0536 Fab in complex with 001428_T278M_L14 SOSIP and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48591:
G002-480-0546 Fab in complex with V703-0537_T278M_L14 SOSIP and BG18 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48283:
61-12A01 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48286:
206-3G08 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48287:
206-9C09 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48290:
273-4D01 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-48291:
253-7A03 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB

EMDB-70490:
BG505 GT1.1 SOSIP in complex with gp41-base epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70491:
BG505 GT1.1 SOSIP in complex with V1V2V3 epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70492:
BG505 GT1.1 SOSIP in complex with C3V5 epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70493:
BG505 GT1.1 SOSIP in complex with CD4bs epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70494:
BG505 GT1.1 SOSIP in complex with gp41 glycan hole epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-70495:
BG505 GT1.1 SOSIP in complex with gp41 fusion peptide epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB

EMDB-41869:
BG505.664 SOSIP in complex with polyclonal antibodies from NHP 8131 (gp120 glycan hole, gp41 glycan hole/fusion peptide and trimer base epitopes)
Method: single particle / : Zhang S, Ward AB

EMDB-41870:
BG505.664 Env SOSIP in complex with polyclonal antibodies from NHP 8131 (gp120-gp120 interface epitope)
Method: single particle / : Zhang S, Ward AB

EMDB-41871:
BG505.664 Env SOSIP in complex with polyclonal antibodies from NHP 8147 (C3/V5, V1/V2/V3 apex, gp41 glycan hole/fusion peptide and trimer base epitopes)
Method: single particle / : Zhang S, Ward AB

EMDB-41872:
BG505.664 Env SOSIP in complex with polyclonal antibodies from NHP 8147 (gp120 glycan hole epitope)
Method: single particle / : Zhang S, Ward AB

EMDB-41972:
GT1.1 SOSIP in complex with wk39 polyclonal antibodies from NHP A12N030 (CD4bs, C3V5 and base epitopes)
Method: single particle / : van Schooten J, Ozorowski G, Ward AB

EMDB-41973:
GT1.1 SOSIP in complex with wk39 polyclonal antibodies from NHP A12N030 (gp41GH/FP and base epitopes)
Method: single particle / : van Schooten J, Ozorowski G, Ward AB

EMDB-41974:
GT1.1 SOSIP in complex with wk39 polyclonal antibodies from NHP DC8G (gp41GH/FP and gp120GH epitopes)
Method: single particle / : van Schooten J, Ozorowski G, Ward AB

EMDB-41975:
GT1.1 SOSIP in complex with wk39 polyclonal antibodies from NHP DC8G (gp120GH and base epitopes)
Method: single particle / : van Schooten J, Ozorowski G, Ward AB

EMDB-41976:
GT1.1 SOSIP in complex with wk39 polyclonal antibodies from NHP DC8G (V1V2V3 and gp120GH epitopes)
Method: single particle / : van Schooten J, Ozorowski G, Ward AB

EMDB-41977:
GT1.1 SOSIP-CC2 in complex with wk80 polyclonal antibodies from NHP 8229 (V1V2V3, C3V5, CD4bs, gp41GH/FP and base epitopes)
Method: single particle / : Sewell LM, Ozorowski G, Ward AB

EMDB-41978:
GT1.1 SOSIP-CC2 in complex with wk80 polyclonal antibodies from NHP 8239 (gp120GH, gp41GH/FP, CD4bs, and base epitopes)
Method: single particle / : Sewell LM, Ozorowski G, Ward AB

EMDB-40796:
BG505 GT1.1 SOSIP in complex with NHP Fabs 12C11 and RM20A3
Method: single particle / : Zhang S, Torres JL, Ozorowski G, Ward AB

EMDB-44246:
Cryo-EM structure of HIV-1 JRFL v6 Env in complex with vaccine-elicited, Membrane Proximal External Region (MPER) directed antibody DH1317.4.
Method: single particle / : Acharya P, Parsons R, Janowska K, Williams WB, Alam M, Haynes BF

EMDB-42352:
SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer consensus (S-GSAS-Omicron-XBB.1.5)
Method: single particle / : Zhang QE, Acharya P

EMDB-42353:
SARS-CoV-2 Omicron-EG.5 3-RBD down Spike Protein Trimer consensus (S-GSAS-Omicron-EG.5)
Method: single particle / : Zhang QE, Acharya P

EMDB-42302:
SARS-CoV-2 Omicron-XBB.1.16 3-RBD down Spike Protein Trimer consensus (S-GSAS-Omicron-XBB.1.16)
Method: single particle / : Zhang QE, Acharya P

EMDB-42342:
SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer consensus (S-RRAR-Omicron-XBB.1.16)
Method: single particle / : Zhang QE, Acharya P

EMDB-42860:
SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer 1 (S-RRAR-Omicron-XBB.1.16)
Method: single particle / : Zhang QE, Acharya P

EMDB-42861:
SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer 2 (S-RRAR-Omicron-XBB.1.16)
Method: single particle / : Zhang QE, Acharya P

EMDB-42862:
SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer 3 (S-RRAR-Omicron-XBB.1.16)
Method: single particle / : Zhang QE, Acharya P

EMDB-42863:
SARS-CoV-2 Omicron-XBB.1.16 3-RBD down Spike Protein Trimer 1 (S-GSAS-Omicron-XBB.1.16)
Method: single particle / : Zhang QE, Acharya P

EMDB-42864:
SARS-CoV-2 Omicron-XBB.1.16 3-RBD down Spike Protein Trimer 2 (S-GSAS-Omicron-XBB.1.16)
Method: single particle / : Zhang QE, Acharya P

EMDB-42866:
SARS-CoV-2 Omicron-XBB.1.16 3-RBD down Spike Protein Trimer 3 (S-GSAS-Omicron-XBB.1.16)
Method: single particle / : Zhang QE, Acharya P

EMDB-42867:
SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer 1 (S-GSAS-Omicron-XBB.1.5)
Method: single particle / : Zhang QE, Acharya P

EMDB-42868:
SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer 2 (S-GSAS-Omicron-XBB.1.5)
Method: single particle / : Zhang QE, Acharya P

EMDB-42869:
SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer 3 (S-GSAS-Omicron-XBB.1.5)
Method: single particle / : Zhang QE, Acharya P

EMDB-42870:
SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer 4 (S-GSAS-Omicron-XBB.1.5)
Method: single particle / : Zhang QE, Acharya P

EMDB-42871:
SARS-CoV-2 Omicron-EG.5 3-RBD down Spike Protein Trimer 1 (S-GSAS-Omicron-EG.5)
Method: single particle / : Zhang QE, Acharya P

EMDB-42872:
SARS-CoV-2 Omicron-EG.5 3-RBD down Spike Protein Trimer 2 (S-GSAS-Omicron-EG.5)
Method: single particle / : Zhang QE, Acharya P

EMDB-42873:
SARS-CoV-2 Omicron-EG.5 3-RBD down Spike Protein Trimer 3 (S-GSAS-Omicron-EG.5)
Method: single particle / : Zhang QE, Acharya P

EMDB-43421:
SARS-CoV-2 Omicron-XBB.1.5 1-RBD up Spike Protein Trimer consensus (S-GSAS-Omicron-XBB.1.5)
Method: single particle / : Zhang QE, Acharya P

EMDB-43422:
SARS-CoV-2 Omicron-XBB.1.5 1-RBD up Spike Protein Trimer 1 (S-GSAS-Omicron-XBB.1.5)
Method: single particle / : Zhang QE, Acharya P

EMDB-43423:
SARS-CoV-2 Omicron-XBB.1.5 1-RBD up Spike Protein Trimer 2 (S-GSAS-Omicron-XBB.1.5)
Method: single particle / : Zhang QE, Acharya P

EMDB-43450:
SARS-CoV-2 Omicron-XBB.1.16 1-RBD up Spike Protein Trimer consensus (S-GSAS-Omicron-XBB.1.16)
Method: single particle / : Zhang QE, Acharya P

EMDB-43451:
SARS-CoV-2 Omicron-XBB.1.16 1-RBD up Spike Protein Trimer 1 (S-GSAS-Omicron-XBB.1.16)
Method: single particle / : Zhang QE, Acharya P

EMDB-43452:
SARS-CoV-2 Omicron-XBB.1.16 1-RBD up Spike Protein Trimer 2 (S-GSAS-Omicron-XBB.1.16)
Method: single particle / : Zhang QE, Acharya P

EMDB-43453:
SARS-CoV-2 Omicron-XBB.1.16 1-RBD up Spike Protein Trimer 3 (S-GSAS-Omicron-XBB.1.16)
Method: single particle / : Zhang QE, Acharya P